🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 9 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/10/1997 | 45,68 | 45,83 | 44,46 | 44,55 | -1,19% | 3,00% | 7.328.664 |
| 23/10/1997 | 45,26 | 45,92 | 44,79 | 45,09 | -2,83% | 2,50% | 9.020.555 |
| 22/10/1997 | 46,49 | 46,67 | 45,65 | 46,40 | +0,13% | 2,18% | 4.771.334 |
| 21/10/1997 | 45,98 | 46,46 | 45,68 | 46,34 | +2,57% | 1,69% | 7.671.779 |
| 20/10/1997 | 45,44 | 45,80 | 44,46 | 45,18 | -0,07% | 2,95% | 8.732.984 |
| 17/10/1997 | 45,50 | 45,86 | 44,61 | 45,21 | -2,94% | 2,75% | 14.385.686 |
| 16/10/1997 | 48,49 | 48,49 | 46,04 | 46,58 | -4,52% | 5,04% | 15.927.923 |
| 15/10/1997 | 48,01 | 49,38 | 47,98 | 48,78 | +0,74% | 2,92% | 5.622.520 |
| 14/10/1997 | 48,01 | 48,75 | 47,68 | 48,43 | +1,56% | 2,24% | 5.616.861 |
| 13/10/1997 | 47,95 | 48,04 | 47,59 | 47,68 | +0,82% | 0,93% | 3.023.899 |
| 10/10/1997 | 47,68 | 47,92 | 47,29 | 47,29 | -1,00% | 1,31% | 4.265.150 |
| 09/10/1997 | 48,54 | 48,57 | 47,77 | 47,77 | -2,08% | 1,66% | 4.357.165 |
| 08/10/1997 | 49,11 | 49,29 | 47,83 | 48,78 | -0,18% | 2,98% | 6.487.330 |
| 07/10/1997 | 48,25 | 48,87 | 47,74 | 48,87 | +1,30% | 2,35% | 5.759.598 |
| 06/10/1997 | 48,43 | 48,43 | 48,07 | 48,25 | +0,25% | 0,74% | 4.294.704 |
| 03/10/1997 | 48,90 | 49,08 | 47,89 | 48,13 | -0,43% | 2,44% | 5.232.664 |
| 02/10/1997 | 48,07 | 48,49 | 47,50 | 48,34 | +0,93% | 2,05% | 3.200.173 |
| 01/10/1997 | 48,63 | 48,63 | 47,38 | 47,89 | +0,44% | 2,58% | 4.863.139 |
| 30/09/1997 | 48,43 | 48,78 | 47,35 | 47,68 | -1,60% | 2,96% | 5.447.294 |
| 29/09/1997 | 47,68 | 48,69 | 47,41 | 48,46 | +1,44% | 2,69% | 4.269.762 |
| 26/09/1997 | 47,71 | 47,89 | 47,53 | 47,77 | +1,01% | 0,75% | 3.923.502 |
| 25/09/1997 | 47,71 | 48,19 | 46,99 | 47,29 | -2,10% | 2,50% | 5.085.106 |
| 24/09/1997 | 49,56 | 49,92 | 48,28 | 48,31 | -2,53% | 3,31% | 7.153.438 |
| 23/09/1997 | 49,11 | 49,68 | 48,49 | 49,56 | +0,97% | 2,43% | 9.248.390 |
| 22/09/1997 | 47,29 | 49,20 | 47,23 | 49,08 | +4,31% | 4,16% | 9.957.048 |
| 19/09/1997 | 46,34 | 47,17 | 46,10 | 47,05 | +1,41% | 2,32% | 6.730.466 |
| 18/09/1997 | 46,76 | 46,85 | 46,31 | 46,40 | -0,77% | 1,15% | 4.690.219 |
| 17/09/1997 | 46,37 | 46,76 | 46,16 | 46,76 | +1,36% | 1,29% | 5.708.875 |
| 16/09/1997 | 45,15 | 46,37 | 45,03 | 46,13 | +3,20% | 2,97% | 5.703.845 |
| 15/09/1997 | 44,70 | 45,09 | 44,22 | 44,70 | +0,94% | 1,93% | 4.717.886 |